CCS
MBOT icon

Crosspoint Capital Strategies’s Microbot Medical MBOT Stock Holding History

Crosspoint Capital Strategies’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1
Closed -$2K – 530
2015
Q4 		$2K Buy
+1
New +$734 ﹤0.01% 921

Other funds holding MBOT

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $1.87B AUM 29.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Crosspoint Capital Strategies's MBOT Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of Microbot Medical (MBOT) in Q1 2016, closing a stake of 1 share — an estimated $2K sold.

Crosspoint Capital Strategies first reported a position in MBOT in Q4 2015 and held it in 1 quarter. The position peaked at $2K in Q4 2015. 34 funds tracked by Wall St. Rank hold MBOT as of Q1 2016.

  • Crosspoint Capital Strategies reported no remaining Microbot Medical position as of Q1 2016 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 1 Microbot Medical share in Q1 2016, an estimated $2K.
  • Crosspoint Capital Strategies first reported a position in Microbot Medical in Q4 2015 and held it in 1 quarter.
  • Crosspoint Capital Strategies's Microbot Medical position peaked at $2K in Q4 2015.
  • 34 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.